Key result
Transapical TAVI was associated with similar long-term survival compared to transfemoral TAVI in a propensity-matched cohort of patients with severe aortic stenosis (HR 0.89; 95% CI 0.72-1.10; P=0.27).
Why the study?
Does transapical TAVI compared to transfemoral TAVI improve survival and reduce complications in patients with severe symptomatic aortic stenosis?
Population
1000 consecutive patients with severe symptomatic aortic stenosis undergoing TAVI
Comparison
Transapical transcatheter aortic valve… vs Transfemoral transcatheter aortic valve…
Design
Cohort
Follow-up
long term
Authors
Loading...
Transapical access was associated with higher complications after matching; leaves open optimal route selection in contemporary TAVI.
Cohort (n=1,000)
No
Does transapical TAVI compared to transfemoral TAVI improve survival and reduce complications in patients with severe symptomatic aortic stenosis?
Hazard Ratio: 0.89 (95% CI 0.72–1.1)
p-value: p=0.27
Transapical and transfemoral TAVI provide comparable long-term survival and 30-day mortality in propensity-matched patients with severe symptomatic aortic stenosis.
Schymik et al. (2015) conducted a cohort in Severe Symptomatic Aortic Stenosis (n=1,000). Transapical transcatheter aortic valve implantation vs. Transfemoral transcatheter aortic valve implantation was evaluated on Long-term survival (HR 0.89, 95% CI 0.72-1.10, p=0.27). Transapical TAVI was associated with similar long-term survival compared to transfemoral TAVI in a propensity-matched cohort of patients with severe aortic stenosis (HR 0.89; 95% CI 0.72-1.10; P=0.27).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: